{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:00:33Z","timestamp":1794002433487,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100013360","name":"Invest Northern Ireland","doi-asserted-by":"publisher","award":["INI-PoC406"],"award-info":[{"award-number":["INI-PoC406"]}],"id":[{"id":"10.13039\/100013360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-NCH2012B-5"],"award-info":[{"award-number":["ARUK-NCH2012B-5"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-Network2012-11"],"award-info":[{"award-number":["ARUK-Network2012-11"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-Network2014-16"],"award-info":[{"award-number":["ARUK-Network2014-16"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-PPG2011B-8"],"award-info":[{"award-number":["ARUK-PPG2011B-8"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.neurobiolaging.2015.11.014","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T22:21:00Z","timestamp":1448922060000},"page":"151-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["Alzheimer's disease\u2013like pathology has transient effects on the brain and blood metabolome"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-1338","authenticated-orcid":false,"given":"Xiaobei","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bin","family":"Nasaruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Passmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Kehoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula L.","family":"McClean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart F.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib1","doi-asserted-by":"crossref","first-page":"920958","DOI":"10.4061\/2011\/920958","article-title":"Ceramide and related sphingolipid levels are not altered in disease associated brain regions of APP and APP\/PS1 mouse models of Alzheimer's disease: relationship with the lack of neurodegeneration?","volume":"2011","author":"Barrier","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib2","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/nprot.2007.376","article-title":"Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts","volume":"2","author":"Beckonert","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","article-title":"Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins","volume":"19","author":"Borchelt","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib5","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1021\/jm000007r","article-title":"Ligands for glutamate receptors: design and therapeutic prospects","volume":"43","author":"Brauner-Osborne","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00023210-200317090-00004","article-title":"The glutamatergic system and Alzheimer's disease\u2014therapeutic implications","volume":"17","author":"Butterfield","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1099-1166(199901)14:1<3::AID-GPS897>3.0.CO;2-7","article-title":"The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease","volume":"14","author":"Cacabelos","year":"1999","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib8","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/bioinformatics\/bti141","article-title":"PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order","volume":"21","author":"Caraux","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2012.07.016","article-title":"Age-related changes in brain metabolites and cognitive function in APP\/PS1 transgenic mice","volume":"235","author":"Chen","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib10","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11306-014-0707-1","article-title":"Molecular phenotyping of a UK population: defining the human serum metabolome","volume":"11","author":"Dunn","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib12","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/NEN.0b013e31826be03c","article-title":"Evidence for premature lipid raft aging in APP\/PS1 double transgenic mice, a model of familial Alzheimer disease","volume":"71","author":"Fabelo","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(00)00128-6","article-title":"Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders","volume":"106","author":"Farooqui","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib14","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/jnr.21268","article-title":"Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide","volume":"85","author":"Farooqui","year":"2007","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1013713905833","article-title":"Metabolomics\u2014the link between genotypes and phenotypes","volume":"48","author":"Fiehn","year":"2002","journal-title":"Plant Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02189113","article-title":"Decreased phospholipase A(2) activity in the brain and in platelets of patients with Alzheimer's disease","volume":"246","author":"Gattaz","year":"1996","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-3223(94)00123-K","article-title":"Decreased phospholipase A(2) activity in Alzheimer brains","volume":"37","author":"Gattaz","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib18","doi-asserted-by":"crossref","first-page":"e99184","DOI":"10.1371\/journal.pone.0099184","article-title":"Inhibition of the polyamine system counteracts beta-amyloid peptide-induced memory impairment in mice: Involvement of extrasynaptic NMDA receptors","volume":"9","author":"Gomes","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib19","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1002\/elps.201400196","article-title":"Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry","volume":"35","author":"Gonzalez-Dominguez","year":"2014","journal-title":"Electrophoresis"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biochi.2015.01.005","article-title":"Deciphering metabolic abnormalities associated with Alzheimer's disease in the APP\/PS1 mouse model using integrated metabolomic approaches","volume":"110C","author":"Gonzalez-Dominguez","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/elps.201400450","article-title":"Metabolomics reveals significant impairments in the immune system of the APP\/PS1 transgenic mice of Alzheimer's disease","volume":"36","author":"Gonzalez-Dominguez","year":"2015","journal-title":"Electrophoresis"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib22","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.bbadis.2014.09.014","article-title":"Region-specific metabolic alterations in the brain of the APP\/PS1 transgenic mice of Alzheimer's disease","volume":"1842","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib23","doi-asserted-by":"crossref","first-page":"e0119452","DOI":"10.1371\/journal.pone.0119452","article-title":"Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease","volume":"10","author":"Graham","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib24","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1021\/ac303163f","article-title":"Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease","volume":"85","author":"Graham","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib25","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s11306-013-0516-y","article-title":"H-1 NMR metabolomics investigation of an Alzheimer's disease (AD) mouse model pinpoints important biochemical disturbances in brain and plasma","volume":"9","author":"Graham","year":"2013","journal-title":"Metabolomics"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib26","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ncb1313","article-title":"Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin","volume":"7","author":"Grimm","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib27","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1016\/j.chroma.2011.07.073","article-title":"From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry","volume":"1218","author":"Grimm","year":"2011","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/chir.10104","article-title":"Glutamate receptor ligands: synthesis, stereochemistry, and enantiopharmacology of methylated 2-aminoadipic acid analogs","volume":"14","author":"Guldbrandt","year":"2002","journal-title":"Chirality"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2012.02.015","article-title":"The effect of ageing on neurogenesis and oxidative stress in the APP(swe)\/PS1(deltaE9) mouse model of Alzheimer's disease","volume":"1449","author":"Hamilton","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib30","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1038\/srep02364","article-title":"Metabolic profiling of Alzheimer's disease brains","volume":"3","author":"Inoue","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in\u00a0vivo: evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2105-7-109","article-title":"VANTED: a system for advanced data analysis and visualization in the context of biological networks","volume":"7","author":"Junker","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2005.08.028","article-title":"Exploratory activity and spatial learning in 12-month-old APP(695)SWE\/co+PS1\/Delta E9 mice with amyloid plaques","volume":"390","author":"Lalonde","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1432-1327.1999.00418.x","article-title":"The human calcium-independent phospholipase A2 gene multiple enzymes with distinct properties from a single gene","volume":"262","author":"Larsson Forsell","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib35","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.1074\/jbc.275.14.9937","article-title":"The genomic organization, complete mRNA sequence, cloning, and expression of a novel human intracellular membrane-associated calcium-independent phospholipase A(2)","volume":"275","author":"Mancuso","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib36","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1073\/pnas.0505513102","article-title":"Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy","volume":"102","author":"Marjanska","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib37","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.nut.2013.01.024","article-title":"Nutritional approaches in the risk reduction and management of Alzheimer's disease","volume":"29","author":"Mi","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib38","doi-asserted-by":"crossref","first-page":"10687","DOI":"10.1021\/bi201426b","article-title":"Induction of methionine sulfoxide reductases protects neurons from amyloid beta protein insults in\u00a0vitro and in\u00a0vivo","volume":"50","author":"Moskovitz","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib39","doi-asserted-by":"crossref","first-page":"e96955","DOI":"10.1371\/journal.pone.0096955","article-title":"Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease","volume":"9","author":"Nkuipou-Kenfack","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib40","series-title":"World Alzheimer Report 2014","author":"Prince","year":"2014"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib41","first-page":"31","article-title":"Effect of lysophosphatidylcholine on transmembrane signal transduction","volume":"63","author":"Prokazova","year":"1998","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib42","doi-asserted-by":"crossref","first-page":"19777","DOI":"10.1074\/jbc.M300466200","article-title":"Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis","volume":"278","author":"Puglielli","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.talanta.2011.04.060","article-title":"Metabolomic analysis of normal (C57BL\/6J, 129S1\/SvImJ) mice by gas chromatography-mass spectrometry: detection of strain and gender differences","volume":"85","author":"Qiao","year":"2011","journal-title":"Talanta"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11306-011-0293-4","article-title":"Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics","volume":"8","author":"Roemisch-Margl","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-008-1351-0","article-title":"Phospholipase A(2) activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease","volume":"202","author":"Schaeffer","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-008-1092-0","article-title":"Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A(2) enzyme","volume":"198","author":"Schaeffer","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib47","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib48","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","article-title":"Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics","volume":"43","author":"Selkoe","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.1.110304.100113","article-title":"Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications","volume":"1","author":"Skovronsky","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/nbdi.1996.0005","article-title":"Cytosolic phospholipase A(2) (cPLA(2)) immunoreactivity is elevated in Alzheimer's disease brain","volume":"3","author":"Stephenson","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib52","doi-asserted-by":"crossref","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","article-title":"Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics","volume":"8","author":"Trushina","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib53","doi-asserted-by":"crossref","first-page":"e32737","DOI":"10.1371\/journal.pone.0032737","article-title":"Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease","volume":"7","author":"Trushina","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ab.2010.07.002","article-title":"Complexity and pitfalls of mass spectrometry-based targeted metabolomics in brain research","volume":"406","author":"Urban","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib55","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neurobiolaging.2008.08.005","article-title":"Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe\/PS1 Delta E9-deleted transgenic mice model of beta-amyloidosis","volume":"31","author":"Volianskis","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib56","doi-asserted-by":"crossref","first-page":"W127","DOI":"10.1093\/nar\/gks374","article-title":"MetaboAnalyst 2.0-A comprehensive server for metabolomic data analysis","volume":"40","author":"Xia","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12264-011-1015-7","article-title":"Biochemical and behavioral characterization of the double transgenic mouse model (APPswe\/PS1dE9) of Alzheimer's disease","volume":"27","author":"Xiong","year":"2011","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11064-008-9673-1","article-title":"Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice","volume":"34","author":"Yao","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(99)00101-9","article-title":"Alzheimer's amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E","volume":"263","author":"Yatin","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2015.11.014_bib60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q","article-title":"Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity","volume":"63","author":"Yatin","year":"2001","journal-title":"J.\u00a0Neurosci. Res."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015005813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015005813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:26:13Z","timestamp":1759317973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015005813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":60,"alternative-id":["S0197458015005813"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.11.014","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer's disease\u2013like pathology has transient effects on the brain and blood metabolome","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}